High conservation of Kaposi sarcoma-associated herpesvirus microRNAs implies important function

Journal of Infectious Diseases

Volumn 195, Issue 5, 2007, Pages 618-620

  Sullivan, Christopher S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; APOPTOSIS; CARCINOGENESIS; CELL CULTURE; CLINICAL FEATURE; CULTURE MEDIUM; EDITORIAL; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; NORTHERN BLOTTING; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA ISOLATION; SYMPTOM; VIRUS CULTURE; VIRUS GENE;

GENE EXPRESSION REGULATION, VIRAL; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA; MICRORNAS; SARCOMA, KAPOSI;

EID: 33847033361     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/511440     Document Type: Editorial

References (54)

1. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003; 67:175-212.
2. Schulz TF. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 2006; 208:187-98.
3. Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005; 132:4645-52.
4. Hammond SM, Sontheimer EJ, Carthew RW. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 2005; 579:5822-9.
5. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6:376-85.
6. Boehm M, Slack FJ. MicroRNA control of lifespan and metabolism. Cell Cycle 2006; 5:837-40.
7. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66:7390-4.
8. Carthew RW. Gene regulation by microRNAs. Curr Opin Genet Dev 2006; 16:203-8.
9. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11:441-50.
10. McManus MT. MicroRNAs and cancer. Semin Cancer Biol 2003; 13:253-8.
11. O'Rourke JR, Swanson MS, Harfe BD. MicroRNAs in mammalian development and tumorigenesis. Birth Defects Res C Embryo Today 2006; 78:172-9.
12. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409:363-6.
13. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436:740-4.
14. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432:231-5.
15. Forstemann K, Tomari Y, Du T, et al. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol 2005; 3:e236.
16. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123:631-40.
17. Gregory RI, Yan KP, Amuthan G, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432:235-40.
18. Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001; 106:23-34.
19. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18:3016-27.
20. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293:834-8.
21. Jiang F, Ye X, Liu X, Fincher L, McKearin D, Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev 2005; 19:1674-9.
22. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001; 15:2654-9.
23. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004; 14:2162-7.
24. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002; 21:4663-70.
25. Saito K, Ishizuka A, Siomi H, Siomi MC. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol 2005; 3:e235.
26. Zeng Y, Yi R, Cullen BR. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005; 24:138-48.
27. Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005; 122:553-63.
28. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73.
29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
30. Cullen BR. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 2006; 7:563-7.
31. Cullen BR. Viruses and microRNAs Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Genet 2006; 38 (Suppl):S25-30.
32. Nair V, Zavolan M. Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol 2006; 14:169-75.
33. Samols MA, Renne R. Virus-encoded microRNAs: a new chapter in virus-host cell interactions. Future Virol 2006; 1:233-42.
34. Sarnow P, Jopling CL, Norman KL, Schutz S, Wehner KA. MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol 2006; 4:651-9.
35. Sullivan CS, Ganem D. MicroRNAs and viral infection. Mol Cell 2005; 20:3-7.
36. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 2006; 442:82-5.
37. Omoto S, Fujii YR. Regulation of human immunodeficiency virus 1 transcription by Nef microRNA. J Gen Virol 2005; 86:751-5.
38. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science 2004; 304:734-6.
39. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005; 435:682-6.
40. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 2005; 102:5570-5.
41. Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12:733-50.
42. Pfeffer S, Sewer A, Lagos-Quintana M, et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005; 2:269-76.
43. Samols MA, Hu J, Skalsky RL, Renne R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 2005; 79:9301-5.
44. Cai X, Cullen BR. Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs. J Virol 2006; 80:2234-42.
45. Pearce M, Matsumura S, Wilson AC. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 2005; 79:14457-64.
46. Marshall V, Parks T, Bagni R, et al. Conservation of virally encoded microRNAs in the Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis 2007; 195:645-59 (in this issue).
47. Whitby D, Marshall VA, Bagni RK, et al. Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 2004; 85:155-63.
48. Zong J, Ciufo DM, Viscidi R, et al. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol 2002; 23:119-48.
49. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20.
50. Gottwein E, Cai X, Cullen BR. A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J Virol 2006; 80:5321-6.
51. Cantalupo P, Doering A, Sullivan CS, et al. Complete nucleotide sequence of polyomavirus SA12. J Virol 2005; 79:13094-104.
52. Burnside KL, Ryan JT, Bielefeldt-Ohmann H, et al. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells. Virology 2006; 354:103-15.
53. Lin CL, Li H, Wang Y, Zhu FX, Kudchodkar S, Yuan Y. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J Virol 2003; 77:5578-88.
54. Sadler R, Wu L, Forghani B, et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 1999; 73:5722-30.